NCT00868413 · Interventional trial
Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Overall registry status Completed
Phase 1
Conditions Chronic Lymphocytic Leukemia
Delaware Valley sites
- Site Reference ID/Investigator# 39613 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory